Care. Every day.

Breakthrough medication support for better health.

Let’s talk
Let’s talk

Immediate and enduring value for organizations across the healthcare landscape.

Health Plans
Life Sciences
Public Health
Health Systems

Reduce ED by 26% and IP by 17%1

For members with type 2 diabetes compared to the control group. This yields cost savings from $2,750-$6,300 per engaged member per year.

150+ exchanges on average between member and care team

Our care team delivers unparalleled engagement, with members reporting 4.8/5 satisfaction and ~20% more exchanges among older members.

Improve clinical outcomes with a 1.8 point reduction in HbA1c for members with A1c > 9

Clients see improved clinical measures across multiple conditions in 3 months. There’s no faster way to improved outcomes & cost savings.

Impact 8+ quality metrics

We drive real clinical impact for HEDIS measures & Star Ratings for a range of chronic conditions, disease management, refill rates, and prevention measures.

Get real-time adherence data

With our program, sponsors, CROs, and clinical trial sites can evaluate adherence (compliance) rates earlier, in real-time, and more accurately to increase successful, cost-efficient clinical trials.

Directly observe 100% of doses

We directly observe 100% of submitted doses using asynchronous video technology — allowing for more accurate efficacy estimates and improved patient support.

Improve patient retention

Our patient-friendly technology and service increase patient understanding of the dosing protocol, keep patients engaged, and reduce barriers to trial participation.

Increase cost efficiency/Reduce Site Burden

Scene offers white-glove support to ensure smooth execution and high-quality data while speeding up trial completion. Our flexible approach accommodates various study protocols and administration methods—whether orals, inhalers, topicals, or injections. Scene delivers reliable, on-time, and cost-effective trial completion without adding an unnecessary burden on the sites.

Secure up to 100% adherence rates2

Medication adherence with our video Directly Observed Therapy (DOT) program is comparable to that of in-person DOT and provides a higher percentage of administered treatment doses.


Save $1,400 per patient3

We help public health departments achieve significant time and cost savings compared with in-person DOT treatments due to reduced employee hours and driving costs.

Expand capacity

Our platform extends limited resources by removing in-person dosing requirements and offering multiple modalities for DOT (asynchronous, livestream & in-person appointments). We also provide Video Review as a Service to further maximize available resources.

Make meaningful, remote care easy

Our flexible, convenient, and easy-to-use app is available in 20+ languages and was built to support low-resource settings.

Reduce readmissions and ED visits

Better coordination and communication tools support patients and encourage adherence at each step, reducing rates of hospital readmission and ED visits.

Improve adherence and administration technique

When patients take their medications properly and improve true medication adherence, they improve health outcomes like A1c values and blood pressure control fast.

Strengthen patient engagement

Our high-touch program allows our care team to connect with patients every day to ensure that no medication adherence issues fall through the cracks.

Gather SDOH data

We successfully identify and help patients overcome root causes of nonadherence with extensive support for issues related to Social Determinants/Drivers of Health (SDOH).

At Scene, we meet patients where they are—every day—to build trusted relationships and empower lasting change.

Illustration of a diverse care team with a pharmacist, nurse, and coach, representing experienced and motivational healthcare professionals.

People

Expert care,
human connection.

Our care team of  pharmacists, nurses, and coaches become partners & advocates that inspire positive behavior change.

Illustration of two people in video calls, representing targeted, science-backed interventions for patient self-management.

Science

Evidence-based,
CDC recommended.

Our science-backed interventions help patients address adherence challenges, build new habits, and self-manage their conditions.

Illustration of an elderly woman holding a smartphone, carrying a child, and holding hands with another child, representing accessible health technology for diverse groups.

Technology

Convenient & easy to use. 
For all.

We’ve been improving health equity in “hard-to-reach” groups for 10+ years. Our app works in low-connectivity areas supporting 20+ languages.

Patients kick-start and sustain improved health for life. Hear it from them.
Play button

Ana

Reduction in A1c from 12 to 7

Play button

Angelica

Reduced asthma exacerbations for her teens

Play button

Ernest

Accountability to hit his health goals

Empowering patients to take control of their condition and take their medication properly delivers unparalleled clinical outcomes.

In a majority Medicaid population, we helped pediatric members with asthma in West Baltimore resolve 100% of inhaler technique errors.5

‍

We helped Medicaid members with an average A1c greater than 9 achieve an average decrease of 1.8 points.4

In patients with Sickle Cell Disease, video DOT for hydroxyurea resulted in observed adherence rates of 88% and improved median medication possession ratio (MPR) from 61.7% to 84.4%.9

Across numerous publications, patients have achieved treatment success rates as high as 96%12 and patient adherence rates consistently ranging from 90-100% with our program.2,12,13

We helped pediatric heart transplant recipients achieve a 90% average adherence rate with a 21.7% reduction in major late ventricular events (MLVI).10

In a pharmacist-led implementation of our program in Nevada, HIV patients achieved a 98% observed adherence rate to life-saving ART therapies.14

In a population of 85% Medicaid members with SUD in a methadone program, we helped participants achieve an 88.6% average observed adherence rate.7

In an SDOH-burdened, injection drug-using HCV population across 8 U.S. regions, our solution drove a 91% sustained virologic response (SVR) with an 84% average observed adherence rate.6

25+ Peer-reviewed Publications

We offer one of the most comprehensive collections of peer-reviewed research in the field of medication adherence. With over 25 publications, our studies demonstrate how our approach to MedEngagement boosts true medication adherence, the fastest way to improve health.

Explore our publications
Collage of peer-reviewed publications demonstrating the effectiveness of technology-enabled medication adherence services.

Our 700+ customers spanning health plans, public health, life sciences, and more are transforming disease management.

Play button

“Engagement has to fit 
into the member’s life”

Mike Rapach, President and CEO of Maryland Medicaid Plan

Watch video

“Scene’s a comprehensive solution that’s helping us drive improvements in outcomes.”

Director of Quality, 
Medicaid MCO

“Kudos to Scene for delivering outcomes that assist in changing the trajectory of someone’s life.”

National Director of Medicaid MCO

Watch video

“We see improvement in our outcomes and not just the A1C control.”

Director of Quality, 
Medicaid MCO

“Scene has been a lifesaver 
for people needing closer monitoring of their medications.”

Public Health Department

“It's such an elegant system. It's truly changed the way we operate.”

Puerto Rico Department of Health

“The Scene team 
worked closely with the trial team to ensure that any administration issues were caught quickly.”

Sr. Director, Clinical Trial Management, CRO

“Scene Health has a
long-standing focus on advancing health
equity through daily connections.”

UnitedHealthcare Community

References

  1. Improvement in utilization for an emerging and high risk population of members with diabetes. Analysis performed by a medical economics team of a large national Medicaid MCO. Cost savings & reduction in ED/IP visits represent impact on Scene engaged members compared to unengaged population.
  2. Morris, S., Miner, M., Rodriguez, T., Stancil, R., Wiltz-Beckham, D., & Chorba, T. (2017). Notes from the field: Tuberculosis control activities after Hurricane Harvey — Texas, 2017. MMWR Morbidity and Mortality Weekly Report, 66(49), 1362–1363. http://dx.doi.org/10.15585/mmwr.mm6649a5
  3. Holzman, S. B., Zenilman, A., & Shah, M. (2018). Advancing patient-centered care in tuberculosis management: A mixed-methods appraisal of video directly observed therapy. Open Forum Infectious Diseases, 5(4), ofy046. https://doi.org/10.1093/ofid/ofy046
  4. McIntire, K., Weis, B., Litwin Ye, L., & Krugman, S. D. (2022). Feasibility of video observed therapy to support controller inhaler use among children in West Baltimore. The Journal of asthma : official journal of the Association for the Care of Asthma, 59(10), 1961–1972. https://doi.org/10.1080/02770903.2021.1984525
  5. Litwin, A. H., Lum, P. J., Taylor, L. E., Mehta, S. H., Tsui, J. I., Feinberg, J., Kim, A. Y., Norton, B. L., Heo, M., Arnsten, J., Meissner, P., Karasz, A., Mckee, M. D., Ward, J. W., Johnson, N., Pericot-Valverde, I., Agyemang, L., Stein, E. S., Thomas, A., Borsuk, C., … HERO Study Group (2022). Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. The lancet. Gastroenterology & hepatology, 7(12), 1112–1127. https://doi.org/10.1016/S2468-1253(22)00275-8
  6. Hallgren, K. A., Darnton, J., Soth, S., Blalock, K. L., Michaels, A., Grekin, P., Saxon, A. J., Woolworth, S., & Tsui, J. I. (2022). Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic. Journal of substance abuse treatment, 143, 108896. https://doi.org/10.1016/j.jsat.2022.108896
  7. Creary, S., Chisolm, D., Stanek, J., et al. (2020). Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease. Pediatric Blood & Cancer, 67, e28250. https://doi.org/10.1002/pbc.28250
  8. Creary, S., Chisolm, D., Stanek, J., Hankins, J., & O'Brien, S. H. (2019). A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study. JMIR mHealth and uHealth, 7(8), e13452. https://doi.org/10.2196/13452
  9. Killian, M. O., Clifford, S., Lustria, M. L. A., Skivington, G. L., & Gupta, D. (2022). Directly observed therapy to promote medication adherence in adolescent heart transplant recipients. Pediatric transplantation, 26(5), e14288. https://doi.org/10.1111/petr.14288
  10. Scene Health. (2023). Case Study: Improving Hypertension Outcomes with a Medicaid Health Plan. Scene Health. Retrieved from https://insights.scene.health/hubfs/Scene%20Public/Case%20Studies/Health%20Plans/Scene%20-%20Health%20Plan%20Case%20Study%20-%20Hypertension.pdf
  11. Perry, A., Chitnis, A., Chin, A., Hoffmann, C., Chang, L., Robinson, M., Maltas, G., Munk, E., & Shah, M. (2021). Real-world implementation of video-observed therapy in an urban TB program in the United States. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 25(8), 655–661. https://doi.org/10.5588/ijtld.21.0170
  12. Holzman, S. B., Zenilman, A., & Shah, M. (2018). Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy. Open forum infectious diseases, 5(4), ofy046. https://doi.org/10.1093/ofid/ofy046
  13. Scene Health. (2022). Emocha Health Rx Healthy Living Flip The ScriptHIV Program Adherence Services Program Review. Scene Health.

‍